Physician profile
James Robert Cohen
NPI 1578557682
$3,422.50
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $775 · 2020: $117 · 2021: $831 · 2022: $1,065 · 2023: $483 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.50 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $916.50 | 2019-2024 | Imfinzi, Enhertu |
| E.R. Squibb & Sons, L.L.C. | $792.18 | 2022-2023 | Onureg, Reblozyl |
| Kite Pharma, INC. | $210.47 | 2019-2022 | |
| Blueprint Medicines Corporation | $204.83 | 2021-2022 | |
| Amgen INC. | $202.47 | 2021-2022 | |
| Seagen INC. | $130.46 | 2019-2023 | |
| Daiichi Sankyo INC. | $127.19 | 2021-2024 | Enhertu |
| Genzyme Corporation | $122.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $118.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $108.59 | 2022 | |
| Incyte Corporation | $106.88 | 2019 | |
| Global Blood Therapeutics, INC. | $99.02 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $77.61 | 2021 | |
| Adc Therapeutics America, INC. | $69.95 | 2022 | |
| Celgene Corporation | $48.53 | 2023 | Pomalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $25.65 | 2019 | |
| Pfizer INC. | $25.00 | 2023 | |
| Beigene USA, INC. | $19.31 | 2023 | Brukinsa |
| Zap Surgical Systems, INC. | $17.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.